Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 15 results for "pfizer drugmaker pfizer"

As AstraZeneca chases rivals, immuno-oncology gets complicated

As AstraZeneca chases rivals, immuno-oncology gets complicated

Three years after Pfizer's failed bid for AstraZeneca, the British drugmaker aims to prove in the coming weeks that its cancer immunotherapy can deliver on bold sales forecasts made during that takeover battle. Central to AstraZeneca's case is a trial called ... Reuters, 1 week ago

30 images for pfizer drugmaker pfizer

First, 1 week ago
Investor's Business Daily, 2 months ago
Malay Mail, 3 months ago, 2 months ago
Motley Fool, 3 months ago
Yahoo! Finance, 3 months ago, 4 months ago, 5 months ago
San Francisco, 6 months ago
Research & Development, 4 months ago

Merck KGaA, Pfizer get priority review for bladder cancer drug

German drugmaker Merck KGaA and U.S. partner Pfizer have been granted priority review status in the United States as they seek to widen the use of immunotherapy drug avelumab to include bladder cancer. The U.S. Food and Drug Administration will review trial ...
 Reuters1 month ago

Pfizer subpoenaed in U.S. intravenous saline solution probe

Pfizer Inc has received grand jury subpoenas from the U.S. Justice Department in connection with an antitrust investigation focusing on drugmakers that market intravenous saline solutions. The drugmaker disclosed the subpoenas in a statement on Wednesday ...
 Reuters1 week ago Pfizer subpoenaed in U.S. over patient assistance plans  Reuters2 months ago Pfizer subpoenaed in US over patient assistance plans  Money Control2 months ago

Roche's Alecensa notches trial win against Pfizer's Xalkori

ZURICH (Reuters) - Roche's Alecensa kept people with a specific lung cancer alive longer without their disease progressing than Pfizer's Xalkori, the Swiss drugmaker said on Monday, as it seeks to move in on the U.S. company's share of early treatment of the ...
 Reuters2 weeks ago

Low-cost male contraceptive finds no takers

It could ease the burden on the 225 million women in developing countries, says Ari Altstedter. IMAGE: Years of human trials on the injectable, sperm-zapping product are coming to an end, and researchers are preparing to submit it for regulatory approval. Photograph: Robert Cianflone/Getty Images Doctors are on the cusp of launching a male contraceptive. But rather than a big pharma lab, the breakthrough is emerging from a university start-up in the heart of rural India. Years of human ...
 Rediff.com3 weeks ago

Chinese drug approval boosts AstraZeneca's lung cancer hopes

LONDON - AstraZeneca has won approval for its lung cancer pill Tagrisso in China, a key market for the potential blockbuster medicine. Tagrisso is designed to help cancer patients with certain genetic mutations that are very common in China and the regulatory ...
 Sify1 month ago

Factbox - Trump tweets have short-lived impact on stocks

NEW YORK (Reuters) - U.S. President Donald Trump's comments about various companies have drawn much attention, and his tweets on Tuesday marked a subtle shift in which they focussed on a sector over a specific company. But while the share prices of most ...
 Sify1 month ago

US STOCKS-Futures slip as investors fret over Trump's policies

* Futures down: Dow 30 pts, S&P 3 pts, Nasdaq 8pts By Yashaswini Swamynathan Jan 31 (Reuters) - U.S. stock index futures fell on Tuesday,the second straight day of decline, as investors focused onPresident Donald Trump's policies that could prove ...
 Sify2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less